Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

ManRos Therapeutics (France) | Researchclopedia

Back to institutions

ManRos Therapeutics (France)

Roscoffcompany

222

Works

27,009

Citations

55

h-index

Top Research Topics

Cystic Fibrosis Research Advances Cancer-related Molecular Pathways Quinazolinone synthesis and applications

Top Researchers

Nicholas J. Wareham University of Essex

2,175 works247,814 citationsh-index: 233

Recent Research

Molecular characterisation of the trafficking rescue of defective ABCB4 variants by roscovitine analogues

Manon Banet,Veronica Crespi,et al.

20260 citations

Down syndrome and intellectual disability research

Synthesis and biological activity

Neonatal Respiratory Health Research

Synthesis and Characterization of Heterocyclic Compounds

Alzheimer's disease research and treatments

Synthesis and Biological Evaluation

14-3-3 protein interactions

Microtubule and mitosis dynamics

Chronic Lymphocytic Leukemia Research

Laurent Meijer ManRos Therapeutics (France)

538 works38,830 citationsh-index: 93

Alan F. List Q Therapeutics (United States)

1,025 works35,474 citationsh-index: 89

Jérôme Honnorat Université Claude Bernard Lyon 1

798 works33,661 citationsh-index: 91

Bernard Payrastre Inserm

364 works16,898 citationsh-index: 72

Isabelle Pin Centre National de la Recherche Scientifique

414 works15,659 citationsh-index: 71

Leucettinib-21 decreases dosage effects of DYRK1A in human trisomy 21 iPSC-derived neural cells

Nicole West,Mattias F Lindberg,et al.

20260 citations

Study of Insulin Treatment Modalities in Adults With Cystic Fibrosis-Related Diabetes After Elexacaftor-Tezacaftor-Ivacaftor Therapy

Luc Rakotoarisoa,François Lefèbvre,et al.

20260 citations

Rhizavidin engineered for eukaryotic expression

Brian Cieslewicz,Cullen Roeder,et al.

20250 citations

Monoclonal antibodies against pathogenic S100A8/9 alarmins can restore hematopoiesis and result in immunomodulation in myelodysplasia and leukemia models

Rahul Sanawar,Ariel Fromowitz,et al.

20250 citations

S100A8/A9 drives T cell exhaustion and compromises the therapeutic efficacy of bispecific antibodies in multiple myeloma.

Adolfo Aleman,Oliver Van Oekelen,et al.

20250 citations